Skip to main content
. 2024 Mar 27;9:26. doi: 10.1038/s41539-024-00229-7

Table 6.

Significant Pathway enrichment results (GAUSS) after correction of multiple testing (FDR < 0.05)

GeneSet Pvalue Phenotype FDR adjust Pa
REACTOME_RNA_POL_III_TRANSCRIPTION 3.36E-08 WO_Total 1.60E-04
BIOCARTA_P35ALZHEIMERS_PATHWAY 3.41E-07 EWR_Total 1.62E-03
REACTOME_P2Y_RECEPTORS 3.94E-07 CVK_Total 1.88E-03
REACTOME_KINESINS 7.07E-07 BDS_Total 3.37E-03
STOSSI_RESPONSE_TO_ESTRADIOL 3.04E-06 RC_MC 1.45E-02
IGLESIAS_E2F_TARGETS_DN 4.29E-06 CWR_Norm 2.04E-02
REACTOME_P2Y_RECEPTORS 5.25E-06 CVD_Total 2.50E-02
PID_S1P_META_PATHWAY 9.02E-06 CDICT_Total 3.88E-02
GOLUB_ALL_VS_AML_DN 1.63E-05 CDICT_Total 3.88E-02
BIOCARTA_AKAPCENTROSOME_PATHWAY 2.00E-05 CCR_Total 4.76E-02
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP 2.00E-05 CCR_Total 4.76E-02
LIM_MAMMARY_LUMINAL_PROGENITOR_UP 2.00E-05 EWR_Total 4.76E-02

Please refer to Table 10 for abbreviations of the phenotypes. Full descriptions of each gene-set can be found by looking up the pathway names at https://www.gsea-msigdb.org/gsea/msigdb/.

aFDR-adjust P: Calculated by the R.program p.adjust using Benjamini-Hochberg procedure (BH).